Yuyu Pharma, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was KRW 2,213.8 million compared to net income of KRW 1,283.52 million a year ago. Basic loss per share from continuing operations was KRW 157 compared to basic earnings per share from continuing operations of KRW 83 a year ago.

Diluted loss per share from continuing operations was KRW 157 compared to diluted earnings per share from continuing operations of KRW 83 a year ago. Basic loss per share was KRW 157 compared to basic earnings per share of KRW 83 a year ago.